News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
744,663 Results
Type
Article (45231)
Company Profile (268)
Press Release (699148)
Multimedia
Podcasts (100)
Webinars (20)
Section
Business (207226)
Career Advice (2165)
Deals (35923)
Drug Delivery (140)
Drug Development (83068)
Employer Resources (175)
FDA (16720)
Job Trends (15274)
News (351690)
Policy (33440)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2690)
Accelerated approval (45)
Adcomms (27)
Allergies (174)
Alliances (50194)
ALS (208)
Alzheimer's disease (1783)
Antibody-drug conjugate (ADC) (438)
Approvals (17069)
Artificial intelligence (640)
Autoimmune disease (259)
Automation (52)
Bankruptcy (367)
Best Places to Work (11856)
BIOSECURE Act (21)
Biosimilars (218)
Biotechnology (176)
Bladder cancer (188)
Brain cancer (73)
Breast cancer (728)
Cancer (5732)
Cardiovascular disease (466)
Career advice (1830)
Career pathing (41)
CAR-T (327)
CDC (61)
Celiac Disease (3)
Cell therapy (867)
Cervical cancer (47)
Clinical research (71756)
Collaboration (2022)
Company closure (5)
Compensation (1332)
Complete response letters (79)
COVID-19 (2799)
CRISPR (106)
C-suite (1073)
Cystic fibrosis (152)
Data (7597)
Decentralized trials (3)
Denatured (28)
Depression (163)
Dermatology (76)
Diabetes (584)
Diagnostics (6994)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (217)
Drug shortages (32)
Duchenne muscular dystrophy (276)
Earnings (91849)
Editorial (70)
Employer branding (22)
Employer resources (154)
Events (122017)
Executive appointments (1072)
FDA (20351)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1691)
Gene editing (231)
Generative AI (54)
Gene therapy (699)
GLP-1 (1076)
Government (4880)
Grass and pollen (6)
Guidances (403)
Healthcare (19464)
HIV (78)
Huntington's disease (55)
IgA nephropathy (93)
Immunology and inflammation (286)
Immuno-oncology (89)
Indications (176)
Infectious disease (3138)
Inflammatory bowel disease (208)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (286)
Interviews (335)
IPO (16779)
IRA (53)
Job creations (3724)
Job search strategy (1530)
JPM (59)
Kidney cancer (18)
Labor market (97)
Layoffs (569)
Leadership (37)
Legal (8112)
Liver cancer (99)
Longevity (32)
Lung cancer (761)
Lymphoma (424)
Machine learning (58)
Management (60)
Manufacturing (1005)
MASH (182)
Medical device (14066)
Medtech (14164)
Mergers & acquisitions (20364)
Metabolic disorders (1492)
mRNA (202)
Multiple sclerosis (184)
NASH (17)
Neurodegenerative disease (403)
Neuropsychiatric disorders (106)
Neuroscience (3276)
Neurotech (1)
NextGen: Class of 2026 (6742)
Non-profit (4747)
Now hiring (76)
Obesity (702)
Opinion (297)
Ovarian cancer (211)
Pain (249)
Pancreatic cancer (290)
Parkinson's disease (356)
Partnered (33)
Patents (583)
Patient recruitment (645)
Peanut (63)
People (60512)
Pharmaceutical (60)
Pharmacy benefit managers (34)
Phase 1 (22322)
Phase 2 (31557)
Phase 3 (23531)
Pipeline (7953)
Policy (333)
Postmarket research (2707)
Preclinical (9588)
Press Release (65)
Prostate cancer (294)
Psychedelics (52)
Radiopharmaceuticals (325)
Rare diseases (1049)
Real estate (6103)
Recruiting (70)
Regulatory (25694)
Reports (55)
Research institute (2477)
Resumes & cover letters (373)
Rett syndrome (36)
RNA editing (22)
RSV (89)
Schizophrenia (178)
Series A (284)
Series B (208)
Service/supplier (11)
Sickle cell disease (115)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (47)
Startups (3672)
State (2)
Stomach cancer (19)
Supply chain (127)
Tariffs (92)
The Weekly (70)
Vaccines (1115)
Venture capital (104)
Weight loss (458)
Women's health (120)
Worklife (21)
Date
Today (40)
Last 7 days (765)
Last 30 days (2789)
Last 365 days (30361)
2026 (10702)
2025 (30461)
2024 (35566)
2023 (40463)
2022 (51607)
2021 (56202)
2020 (54843)
2019 (47589)
2018 (35812)
2017 (32633)
2016 (32250)
2015 (38296)
2014 (32051)
2013 (27197)
2012 (29458)
2011 (30147)
2010 (28495)
Location
Africa (778)
Alabama (91)
Alaska (7)
Arizona (346)
Arkansas (14)
Asia (40432)
Australia (6680)
California (12861)
Canada (3684)
China (1322)
Colorado (550)
Connecticut (555)
Delaware (390)
Europe (88047)
Florida (1929)
Georgia (413)
Hawaii (3)
Idaho (63)
Illinois (1042)
India (89)
Indiana (587)
Iowa (24)
Japan (517)
Kansas (131)
Kentucky (51)
Louisiana (40)
Maine (75)
Maryland (1556)
Massachusetts (9217)
Michigan (361)
Minnesota (698)
Mississippi (6)
Missouri (146)
Montana (34)
Nebraska (29)
Nevada (139)
New Hampshire (86)
New Jersey (3413)
New Mexico (29)
New York (3388)
North Carolina (1641)
North Dakota (9)
Northern California (6417)
Ohio (380)
Oklahoma (24)
Oregon (42)
Pennsylvania (2589)
Puerto Rico (28)
Rhode Island (51)
South America (1204)
South Carolina (85)
South Dakota (2)
Southern California (5061)
Tennessee (208)
Texas (2038)
United States (45581)
Utah (385)
Vermont (1)
Virginia (309)
Washington D.C. (81)
Washington State (1033)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
744,663 Results for "sysmex america inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sysmex America Expands CN™-Series with CN-9000 to Help Labs of All Sizes Optimize Workflow
January 22, 2026
·
2 min read
Press Releases
Fujirebio and Sysmex Begin Sales Collaboration for Dementia Testing
February 5, 2026
·
5 min read
Press Releases
Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference
April 30, 2026
·
1 min read
BioMidwest
Sysmex America Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States
Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.
April 2, 2024
·
2 min read
Press Releases
Sysmex America Receives FDA Clearance for Automated Blood Coagulation Analyzer CN-Series CN-6000™
June 26, 2025
·
2 min read
Press Releases
Modular Genetics, Inc. joins New American Industrial Alliance to Reindustrialize America
March 5, 2026
·
1 min read
BioMidwest
Sysmex America Becomes Exclusive Distributor of vermicon VIT® System in Canada, Latin America and Americas
Sysmex America, Inc., a leading diagnostic solutions company, has been named the exclusive distributor of vermicon identification technology System in Canada, Latin America and all the Americas.
December 14, 2023
·
2 min read
Press Releases
Elicio Therapeutics to Present at the Bank of America Healthcare Conference
April 30, 2026
·
2 min read
Press Releases
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference
April 30, 2026
·
4 min read
Press Releases
Sysmex America Expands Line of 3-Part Differential Automated Hematology Analyzers with XQ-320
March 3, 2025
·
2 min read
1 of 74,467
Next
